Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma.
about
Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I study of pegylated int ...... ients with malignant melanoma.
@en
Phase I study of pegylated int ...... ients with malignant melanoma.
@nl
type
label
Phase I study of pegylated int ...... ients with malignant melanoma.
@en
Phase I study of pegylated int ...... ients with malignant melanoma.
@nl
prefLabel
Phase I study of pegylated int ...... ients with malignant melanoma.
@en
Phase I study of pegylated int ...... ients with malignant melanoma.
@nl
P2093
P2860
P356
P1476
Phase I study of pegylated int ...... ients with malignant melanoma.
@en
P2093
Hidefumi Wada
Hisashi Uhara
Keiko Yamamoto
Kenji Matsuda
Naoya Yamazaki
Takashi Shimamoto
Yoshio Kiyohara
P2860
P304
P356
10.1111/1346-8138.13338
P577
2016-04-18T00:00:00Z